Disc Medicine (IRON) News Today

Marshall Wace LLP acquired a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 12,300 shares of the company's stock, valued at approximatel

Teachers Retirement System of The State of Kentucky purchased a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 14,102 shares of t

Nantahala Capital Management LLC purchased a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 150,000 shares of the company's stock, valued at approximately $6,760,000

Perceptive Advisors LLC reduced its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 13.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 553,437 shares of the company's stock after sel

Frazier Life Sciences Management L.P. lifted its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 123.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,754,834 shares of the company's stock after b

Blue Owl Capital Holdings LP increased its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 38.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 215,260 shares of the company's stock after a

Point72 Asset Management L.P. acquired a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 761,429 shares of the company's st

Deerfield Management Company L.P. Series C increased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 53.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,023,265 shares of the company's stock after acquiring an additiona

Shares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and seven have issued a buy ra

Logos Global Management LP purchased a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 925,000 shares of the company's stock, valued

Disc Medicine (NASDAQ:IRON) Shares Down 5%

Ally Bridge Group NY LLC purchased a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 166,500 shares of the company's stock, valued at approximately $7,504,000

Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totalling 1,480,000 shares, an increase of 9.6% from the August 15th total of 1,350,000 shares. Based on an average daily trading volume, of 297,200 shares, the short-interest ratio is currently 5.0 days. Currently, 9.6% of the shares of the stock are sold short.

Sofinnova Investments Inc. lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 373.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,256 shares of the company's stock after buy

HC Wainwright reiterated a "buy" rating and issued a $70.00 target price on shares of Disc Medicine in a report on Monday.

Atlas Venture Life Science Advisors LLC increased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 9.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,509,456 shares of the company's stock after acquiring an ad

Victory Capital Management Inc. boosted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 46.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 312,049 shares of the company's stock after purcha

First Turn Management LLC lowered its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 45.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 138,907 shares of the company's stock a

Shares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the

Disc Medicine (NASDAQ:IRON) Shares Up 4%

Disc Medicine (NASDAQ:IRON) Shares Gap Up to $49.31

Wells Fargo & Company initiated coverage on Disc Medicine in a research report on Thursday. They set an "overweight" rating and a $75.00 target price on the stock.

Disc Medicine, Inc. (NASDAQ:IRON - Free Report) - Stock analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for shares of Disc Medicine in a research note issued on Monday, August 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings per share of